Puja Sapra Selected Research

Puja Sapra Research Topics

Disease

39	Neoplasms (Cancer) 03/2024 - 02/2002
5	Lymphoma (Lymphomas) 10/2015 - 12/2002
4	Ovarian Neoplasms (Ovarian Cancer) 12/2019 - 09/2015
3	Breast Neoplasms (Breast Cancer) 10/2020 - 09/2015
3	Tics (Tic) 11/2017 - 01/2013
3	Hypoxia (Hypoxemia) 09/2011 - 11/2008
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 01/2018
2	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 04/2008
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2017 - 01/2013
2	Triple Negative Breast Neoplasms 11/2017 - 09/2015
2	Neoplasm Metastasis (Metastasis) 11/2017 - 11/2008
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2017 - 10/2015
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 10/2015 - 10/2009
2	Neuroblastoma 10/2010 - 01/2003
2	B-Cell Lymphoma (Lymphoma, B Cell) 04/2004 - 02/2004
1	Leukemia 01/2021
1	Melanoma (Melanoma, Malignant) 01/2021
1	Lung Neoplasms (Lung Cancer) 10/2020
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2020
1	Ovarian Epithelial Carcinoma 01/2019
1	Myocarditis (Carditis) 01/2019
1	Stomach Neoplasms (Stomach Cancer) 01/2017
1	Residual Neoplasm 01/2017
1	Hematologic Neoplasms (Hematological Malignancy) 10/2015
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 10/2015
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 10/2015
1	Prostatic Neoplasms (Prostate Cancer) 12/2011

Drug/Important Bio-Agent (IBA)

24	Immunoconjugates (Immunoconjugate)IBA 01/2022 - 07/2005
6	Monoclonal AntibodiesIBA 01/2023 - 02/2004
6	AntigensIBA 01/2021 - 11/2012
5	A1mcMMAFIBA 12/2019 - 01/2013
5	Liposomes (Liposome)IBA 10/2005 - 02/2002
4	auristatinIBA 01/2022 - 01/2016
4	LigandsIBA 01/2021 - 02/2002
4	Glycoproteins (Glycoprotein)IBA 12/2019 - 06/2015
4	EZN-2208IBA 09/2011 - 03/2008
4	Irinotecan (Camptosar)FDA LinkGeneric 09/2011 - 03/2008
4	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2010 - 01/2003
3	Immune Checkpoint InhibitorsIBA 03/2024 - 02/2016
3	Ado-Trastuzumab EmtansineIBA 10/2020 - 10/2013
3	Antineoplastic Agents (Antineoplastics)IBA 06/2015 - 03/2008
3	Immunoglobulin G (IgG)IBA 11/2012 - 02/2004
3	Proteins (Proteins, Gene)FDA Link 12/2011 - 11/2008
3	Messenger RNA (mRNA)IBA 12/2011 - 11/2008
3	LuciferasesIBA 12/2011 - 10/2010
2	Histones (Histone)IBA 01/2022 - 10/2010
2	Neoplasm Antigens (Tumor Antigens)IBA 01/2021 - 11/2015
2	Cysteine (L-Cysteine)FDA Link 10/2020 - 01/2017
2	Carboplatin (JM8)FDA LinkGeneric 12/2019 - 01/2019
2	AntibodiesIBA 10/2016 - 10/2010
2	CalicheamicinsIBA 10/2015 - 09/2015
2	Surface Antigens (Surface Antigen)IBA 09/2015 - 02/2004
2	Transcription Factors (Transcription Factor)IBA 12/2011 - 11/2008
2	Antisense OligonucleotidesIBA 12/2011 - 02/2010
2	Topoisomerase I InhibitorsIBA 09/2011 - 10/2010
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2011 - 10/2010
2	Vincristine (Oncovin)FDA LinkGeneric 10/2010 - 02/2004
2	ProdrugsIBA 10/2010 - 04/2008
2	liposomal doxorubicin (Doxil)FDA Link 04/2004 - 02/2004
2	Immunoglobulin Fab FragmentsIBA 02/2004 - 01/2003
1	CytokinesIBA 03/2024
1	Interleukin-12 (IL 12)IBA 03/2024
1	AZD5305IBA 01/2023
1	Extracellular Matrix ProteinsIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Fibronectins (Fibronectin)IBA 01/2022
1	Enterotoxin ReceptorsIBA 01/2020
1	PlatinumIBA 01/2019
1	Gemtuzumab (Mylotarg)FDA Link 01/2018
1	Valine (L-Valine)FDA Link 11/2017
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 11/2017
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 11/2017
1	CitrullineIBA 11/2017
1	Brentuximab VedotinIBA 01/2017
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2017
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2016
1	Sialic Acid Binding Ig-like Lectin 2IBA 10/2015
1	Inotuzumab OzogamicinIBA 10/2015
1	Rituximab (Mabthera)FDA Link 10/2015
1	PF-06647263IBA 09/2015
1	Cadherins (E-Cadherin)IBA 09/2015
1	ClaudinsIBA 09/2015
1	Ephrin-A4 (Ephrin A4)IBA 09/2015
1	DNA (Deoxyribonucleic Acid)IBA 09/2015
1	trans-sodium crocetinate (crocetin)IBA 10/2013
1	Immunoglobulins (Immunoglobulin)IBA 11/2012
1	abirateroneIBA 12/2011
1	Androgen Receptors (Androgen Receptor)IBA 12/2011
1	Testosterone (Sustanon)FDA Link 12/2011
1	AndrogensIBA 12/2011

Therapy/Procedure

16	Therapeutics 01/2023 - 10/2005
5	Drug Therapy (Chemotherapy) 01/2021 - 04/2004
3	Injections 03/2008 - 02/2004
2	Aftercare (After-Treatment) 11/2017 - 09/2011
1	Immunotherapy 01/2020
1	Induction Chemotherapy 01/2018
1	Transplantation 11/2017
1	Remission Induction 01/2017
1	Combination Drug Therapy (Combination Chemotherapy) 01/2017
1	Castration 12/2011